Order Article Reprints

Boonsit T, Chatatikun M, Sirirattanakul S, Pattaranggoon NC, Sama-ae I, Kawakami F, Imai M, Raungrut P, Phongphithakchai A, Tedasen A, et al. Tiliacorinine as a Promising Candidate for Cholangiocarcinoma Therapy via Oxidative Stress Molecule Modulation: A Study Integrating Network Pharmacology, Molecular Docking and Molecular Dynamics Simulation. Antioxidants. 2025; 14(11):1273. https://doi.org/10.3390/antiox14111273

Boonsit, Tavisa, Moragot Chatatikun, Suphasarang Sirirattanakul, Nawanwat C. Pattaranggoon, Imran Sama-ae, Fumitaka Kawakami, Motoki Imai, Pritsana Raungrut, Atthaphong Phongphithakchai, Aman Tedasen, and et al. 2025. "Tiliacorinine as a Promising Candidate for Cholangiocarcinoma Therapy via Oxidative Stress Molecule Modulation: A Study Integrating Network Pharmacology, Molecular Docking and Molecular Dynamics Simulation" Antioxidants 14, no. 11: 1273. https://doi.org/10.3390/antiox14111273

Boonsit, T., Chatatikun, M., Sirirattanakul, S., Pattaranggoon, N. C., Sama-ae, I., Kawakami, F., Imai, M., Raungrut, P., Phongphithakchai, A., Tedasen, A., & Maungchanburi, S. (2025). Tiliacorinine as a Promising Candidate for Cholangiocarcinoma Therapy via Oxidative Stress Molecule Modulation: A Study Integrating Network Pharmacology, Molecular Docking and Molecular Dynamics Simulation. Antioxidants, 14(11), 1273. https://doi.org/10.3390/antiox14111273